FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients – FDA.gov

0
6

FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients
FDA.gov
Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in

and more »

LEAVE A REPLY